Portola Pharmaceuticals Company
Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
South San Francisco, California, United States
Founded Date:
2003
Estimated Revenue:
$10M to $50M
Register and Claim Ownership